Human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells are promising sources for the cell therapy of muscle diseases and can serve as powerful experimental tools for skeletal muscle research, provided an effective method to induce skeletal muscle cells is established. However, the current methods for myogenic differentiation from human ES cells are still inefficient for clinical use, while myogenic differentiation from human iPS cells remains to be accomplished. Here, we aimed to establish a practical differentiation method to induce skeletal myogenesis from both human ES and iPS cells. To accomplish this goal, we developed a novel stepwise culture method for the selective expansion of mesenchymal cells from cell aggregations called embryoid bodies. These mesenchymal cells, which were obtained by dissociation and re-cultivation of embryoid bodies, uniformly expressed CD56 and the mesenchymal markers CD73, CD105, CD166, and CD29, and finally differentiated into mature myotubes in vitro. Furthermore, these myogenic mesenchymal cells exhibited stable long-term engraftment in injured muscles of immunodeficient mice in vivo and were reactivated upon subsequent muscle damage, increasing in number to reconstruct damaged muscles. Our simple differentiation system facilitates further utilization of ES and iPS cells in both developmental and pathological muscle research and in serving as a practical donor source for cell therapy of muscle diseases.
References
[1]
Wallace GQ, McNally EM (2009) Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu Rev Physiol 71: 37–57.
[2]
Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9: 493–495.
[3]
Wang YX, Rudnicki MA (2012) Satellite cells, the engines of muscle repair. Nat Rev Mol Cell Biol 13: 127–133.
[4]
Scharner J, Zammit PS (2011) The muscle satellite cell at 50: the formative years. Skeletal Muscle 1: 28.
[5]
Cerletti M, Shadrach J, Jurga S, Sherwood R, Wagers A (2008) Regulation and Function of Skeletal Muscle Stem Cells. Cold Spring Harb Symp Quant Biol 73: 317–322.
[6]
Jejurikar SS, Kuzon WM Jr (2003) Satellite cell depletion in degenerative skeletal muscle. Apoptosis 8: 573–578.
[7]
Bulfield G, Siller WG, Wight PA, Moore KJ (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189–1192.
[8]
Dangain J, Vrbova G (1984) Muscle development in mdx mutant mice. Muscle Nerve 7: 700–704.
[9]
Péault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, et al. (2007) Stem and Progenitor Cells in Skeletal Muscle Development, Maintenance, and Therapy. Mol Ther 15: 867–877.
[10]
Meregalli M, Farini A, Parolini D, Maciotta S, Torrente Y (2010) Stem cell therapies to treat muscular dystrophy: progress to date. BioDrugs 24: 237–247.
[11]
Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G (2010) Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 120: 11–19.
[12]
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154–156.
[13]
Thomson JA (1998) Embryonic Stem Cell Lines Derived from Human Blastocysts. Science 282: 1145–1147.
[14]
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676.
[15]
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861–872.
[16]
Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, et al. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101–106.
[17]
Grskovic M, Javaherian A, Strulovici B, Daley GQ (2011) Induced pluripotent stem cells – opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 10: 915–929.
[18]
Bellin M, Marchetto MC, Gage FH, Mummery CL (2012) Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol. doi:10.1038/nrm3448.
[19]
Salani S, Donadoni C, Rizzo F, Bresolin N, Comi GP, et al. (2012) Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. J Cellular Mol Med 16: 1353–1364.
[20]
Rohwedel J, Maltsev J, Bober E, Arnold HH, Hescheler J, et al. (1994) Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: Developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol 184: 87–101.
[21]
Guan K, Rohwedel J, Wobus AM (1999) Embryonic stem cell differentiation models: cardiogenesis, myogenesis, neurogenesis, epithelial and vascular smooth muscle cell differentiation in vitro. Cytotechnology 30: 211–226.
[22]
Zheng JK, Wang Y, Karandikar A, Wang Q, Gai H, et al. (2006) Skeletal myogenesis by human embryonic stem cells. Cell Res 16: 713–722.
[23]
Mahmood A, Harkness L, Schr？der HD, Abdallah BM, Kassem M (2010) Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. J Bone Miner Res 25: 1216–1233.
[24]
Ryan T, Liu J, Chu A, Wang L, Blais A, et al. (2011) Retinoic Acid Enhances Skeletal Myogenesis in Human Embryonic Stem Cells by Expanding the Premyogenic Progenitor Population. Stem Cell Rev 8: 482–493.
[25]
Barberi T, Willis LM, Socci ND, Studer L (2005) Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2: e161.
[26]
Barberi T, Bradbury M, Dincer Z, Panagiotakos G, Socci ND, et al. (2007) Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13: 642–648.
[27]
Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, et al. (1988) MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242: 405–411.
[28]
Ozasa S, Kimura S, Ito K, Ueno H, Ikezawa M, et al. (2007) Efficient conversion of ES cells into myogenic lineage using the gene-inducible system. Biochem Biophys Res Commun 357: 957–963.
[29]
Darabi R, Gehlbach K, Bachoo RM, Kamath S, Osawa M, et al. (2008) Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 14: 134–143.
[30]
Darabi R, Arpke RW, Irion S, Dimos JT, Grskovic M, et al. (2012) Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice. Cell Stem Cell 10: 610–619.
[31]
Chang H, Yoshimoto M, Umeda K, Iwasa T, Mizuno Y, et al. (2009) Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells. FASEB J 23: 1907–1919.
[32]
Mizuno Y, Chang H, Umeda K, Niwa A, Iwasa T, et al. (2010) Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 24: 2245–2253.
[33]
Suemori H, Yasuchika K, Hasegawa K, Fujioka T, Tsuneyoshi N, et al. (2006) Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem Biophys Res Commun 345: 926–932.
[34]
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, et al. (2002) NOD/SCID/gamma(c) (null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175–3182.
[35]
Buckingham M, Relaix F (2007) The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu Rev Cell Dev Biol 23: 645–673.
[36]
Bismuth K, Relaix F (2010) Genetic regulation of skeletal muscle development. Exp Cell Res 316: 3081–3086.
[37]
Bentzinger CF, Wang YX, Rudnicki MA (2012) Building muscle: molecular regulation of myogenesis. Cold Spring Harb Perspect Biol 4.
[38]
Olivier EN, Rybicki AC, Bouhassira EE (2006) Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24: 1914–1922.
[39]
Trivedi P, Hematti P (2008) Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Experimental Hematology 36: 350–359.
